David Malcom Rodman insider trades

Open-market stock purchases and sales by David Malcom Rodman, Chief Medical Officer at Mineralys Therapeutics, Inc, from SEC Form 4 filings since Jul 1, 2016.

Recent trades

DateStockTradeValue
Aug 10, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Aug 10, 2026MLYS Mineralys Therapeutics, IncSold$58.8K
Jul 17, 2026MLYS Mineralys Therapeutics, IncSold$11K
Jul 17, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jul 15, 2026MLYS Mineralys Therapeutics, IncSold$169K
Jul 13, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jul 13, 2026MLYS Mineralys Therapeutics, IncSold$388K
Jul 13, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jul 13, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jul 9, 2026MLYS Mineralys Therapeutics, IncSold$65.8K
Jul 9, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jun 17, 2026MLYS Mineralys Therapeutics, IncSold$115K
Jun 17, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jun 17, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jun 15, 2026MLYS Mineralys Therapeutics, IncSold$235K
Jun 15, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jun 12, 2026MLYS Mineralys Therapeutics, IncSold$152K
Jun 12, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jun 10, 2026MLYS Mineralys Therapeutics, IncSold$54.3K
Jun 10, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
May 18, 2026MLYS Mineralys Therapeutics, IncSold$11.5K
May 18, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
May 13, 2026MLYS Mineralys Therapeutics, IncSold$402K
May 13, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
May 13, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—

Companies traded

  • MLYS Mineralys Therapeutics, Inc: 57 sales, last Aug 10, 2026
  • NVLS Nivalis Therapeutics, Inc: 3 sales, last Jan 4, 2017

Get free alerts when David Malcom Rodman files a new trade →